Glenmark Pharmaceuticals s.r.o., Synthon B.V., Synthon Hispania S.L.
PolandAll drugs from this manufacturer
-
The medicine is used in adult men for the treatment of prostate cancer that has metastasized to other parts of the body. It works by inhibiting the production of testosterone, which can slow the growth of the tumor.
Dosage form: tablets
Active substance Dosage abiraterone acetate 250 mg ATC: L02BX03
-
This medicine is intended for adult men with prostate cancer that has metastasized to other parts of the body. It works by inhibiting the production of testosterone, which can slow the growth of the tumor.
Dosage form: tablets, film-coated
Active substance Dosage abiraterone acetate 500 mg ATC: L02BX03
-
The medicine is intended for adults with multiple myeloma. It is used in combination with other medicines (bortezomib and dexamethasone or dexamethasone alone) to inhibit the growth of the cancer.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC: L04AX06
-
The medicine is used in adults with multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC: L04AX06
-
The medicine is used in adults to treat multiple myeloma. It may be taken in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC: L04AX06
-
The medicine is intended for the treatment of adults with multiple myeloma (a type of white blood cell cancer). It is used in combination with other medicines, such as bortezomib and dexamethasone, or alone with dexamethasone, depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC: L04AX06